Speaker Profile
M.D., Joanne Knight Distinguished Professor of Neurology at Washington University School of Medicine,director of the Consortium for Biomedical Research and AI in Neurodegeneration (C-BRAIN), Washington U.
Biography
Dr. Bateman's current research focuses on accelerating biomedical breakthroughs through artificial intelligence and machine learning in neurodegeneration. By leading initiatives centered on advanced technology, he guides the development of "AI Scientist" platforms. These scientist-in-the-loop systems leverage generative AI, neural networks, and deep learning to synthesize complex literature, analyze multi-omic datasets, and optimize experimental designs for Alzheimer's drug discovery.
In addition to AI-driven research, he pioneered the first high-precision blood tests for Alzheimer’s disease and guides major global research networks and clinical trials units. His work integrates clinical data with predictive machine learning models to map disease pathology decades before symptoms emerge. An elected member of the National Academy of Medicine and National Academy of Inventors, his current mission focuses on scaling global human-AI collaboration to transform patient outcomes.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
David Liebeskind, UCLA
PMWC Award Ceremony
• Li-Huei Tsai, MIT Picower Institute (Pioneer)
• Thomas C. Südhof, Stanford (Nobel Laureate, Pioneer)
• David Holtzman, WashU (Pioneer)
• Henrik Zetterberg, UCL / Gothenburg (Luminary)
Featured Speakers
• Thomas C. Südhof, Stanford
• Li-Huei Tsai, MIT Picower Institute
• David Holtzman, WashU
• Henrik Zetterberg, UCL / Gothenburg
• Mark Mintun, Lilly
• Randall Bateman, WashU
• Nikolaos Mellios, Circular Genomics
• Robert Rissman, USC
• Lynn Kramer, Eisai
• Thomas F. Tropea, University of Pennsylvania
• Ari J. Green, UCSF
• Diane Chan, Mass General Brigham
• Leslie Shaw, University of Pennsylvania
• Prashanthi Vemuri, Mayo Clinic
• Kejal Kantarci, Mayo Clinic
• Dan Huddleston, Lightbox Science
• Patrick Brannelly, 10K Brains
• Allan Levey, Emory
From Blood Test to Treatment
Are we finally diagnosing Alzheimer's early enough to change care?
Precision Diagnostics Across Neurology
From biomarker to bedside across neurological disease.
Neurodegeneration Beyond Alzheimer's
Parkinson's, ALS, and FTD in the precision era.
AI & Imaging Across Neurological Disease
Precision phenotyping in stroke, epilepsy, and neurodegeneration.
Why Precision Neurology Is Not Scaling
The evidence, infrastructure, access, and workflow barriers that must be fixed.
Harnessing Brain Rhythms
Gamma oscillations, brain circuits, and the future of neurotherapy.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
